Integral Health Asset Management, LLC Buys Anthem Inc, Biogen Inc, Regeneron Pharmaceuticals Inc, Sells Intellia Therapeutics Inc, Charles River Laboratories International Inc, McKesson Corp

• New Purchases: BIIB, REGN, UHS, SNY, ABC, EW, A, FOLD, AGL, BNTX, ALKS, IRTC, ACRS, SIBN, APLS, DTIL, UNH, MCRB, ONEM, ALT, HRTX, AXGN, TRIL, FMTX, CMRX, LBPH,
• Added Positions: ANTM, SAGE, ZNTL, GMED, MDT, FATE, TFX, NTRA, RLAY, ACCD, KPTI, ARNA, AERI, REPL, PTCT, MYOV, PNTG, CCXI, AVTX, KURA, MGTA,
• Reduced Positions: NTLA, NVST, DHR, ACHC, ZBH, BCRX, ZLAB, LHCG, ALNY, BMRN, BPMC, PKI, DNLI, AGIO, ALEC, KDMN, NVRO, RETA, ARDX,
• Sold Out: CRL, MCK, CNC, MRK, LH, MGNX, BDX, EXEL, NSTG, HZNP, BMY, AMRN, VRTX, PODD, THC, INSM, ALLO, CVS, SWAV, RARE, TVTX, KZR,

For the details of Integral Health Asset Management, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/integral+health+asset+management%2C+llc/current-portfolio/portfolio

1. Anthem Inc (ANTM) - 50,000 shares, 5.26% of the total portfolio. Shares added by 233.33%
2. Acadia Healthcare Co Inc (ACHC) - 260,000 shares, 4.49% of the total portfolio. Shares reduced by 24.64%
3. Arena Pharmaceuticals Inc (ARNA) - 225,000 shares, 4.22% of the total portfolio. Shares added by 7.14%
4. Cytokinetics Inc (CYTK) - 700,000 shares, 3.81% of the total portfolio.
5. Sage Therapeutics Inc (SAGE) - 224,000 shares, 3.50% of the total portfolio. Shares added by 55.56%

Integral Health Asset Management, LLC initiated holding in Biogen Inc. The purchase prices were between $259 and $414.71, with an estimated average price of $301.69. The stock is now traded at around $345.015000. The impact to a portfolio due to this purchase was 3.34%. The holding were 35,000 shares as of 2021-06-30.

Integral Health Asset Management, LLC initiated holding in Regeneron Pharmaceuticals Inc. The purchase prices were between $472.8 and $558.54, with an estimated average price of $505.57. The stock is now traded at around $673.770000. The impact to a portfolio due to this purchase was 2.84%. The holding were 18,500 shares as of 2021-06-30.

Integral Health Asset Management, LLC initiated holding in Universal Health Services Inc. The purchase prices were between $133.39 and $160.6, with an estimated average price of $150.78. The stock is now traded at around $157.090000. The impact to a portfolio due to this purchase was 2.62%. The holding were 65,000 shares as of 2021-06-30.

Integral Health Asset Management, LLC initiated holding in Sanofi SA. The purchase prices were between $49.36 and $54.25, with an estimated average price of $52.12. The stock is now traded at around $52.130000. The impact to a portfolio due to this purchase was 2.54%. The holding were 175,000 shares as of 2021-06-30.

Integral Health Asset Management, LLC initiated holding in AmerisourceBergen Corp. The purchase prices were between $114.32 and $125.85, with an estimated average price of $118.07. The stock is now traded at around $119.870000. The impact to a portfolio due to this purchase was 2.21%. The holding were 70,000 shares as of 2021-06-30.

Integral Health Asset Management, LLC initiated holding in Edwards Lifesciences Corp. The purchase prices were between $83.64 and $104.76, with an estimated average price of $93.97. The stock is now traded at around $118.140000. The impact to a portfolio due to this purchase was 1.85%. The holding were 65,000 shares as of 2021-06-30.

Integral Health Asset Management, LLC added to a holding in Anthem Inc by 233.33%. The purchase prices were between $352.19 and $401.9, with an estimated average price of $381.62. The stock is now traded at around $370.090000. The impact to a portfolio due to this purchase was 3.68%. The holding were 50,000 shares as of 2021-06-30.

Integral Health Asset Management, LLC added to a holding in Sage Therapeutics Inc by 55.56%. The purchase prices were between $54.88 and $79.29, with an estimated average price of $70.83. The stock is now traded at around $44.755000. The impact to a portfolio due to this purchase was 1.25%. The holding were 224,000 shares as of 2021-06-30.

Integral Health Asset Management, LLC added to a holding in Zentalis Pharmaceuticals Inc by 212.50%. The purchase prices were between $37.41 and $62.25, with an estimated average price of $53.28. The stock is now traded at around $66.490000. The impact to a portfolio due to this purchase was 1.24%. The holding were 125,000 shares as of 2021-06-30.

Integral Health Asset Management, LLC added to a holding in Globus Medical Inc by 73.33%. The purchase prices were between $61.67 and $77.53, with an estimated average price of $70.83. The stock is now traded at around $82.565000. The impact to a portfolio due to this purchase was 1.17%. The holding were 130,000 shares as of 2021-06-30.

Integral Health Asset Management, LLC added to a holding in Medtronic PLC by 60.00%. The purchase prices were between $118.13 and $131.5, with an estimated average price of $125.35. The stock is now traded at around $133.860000. The impact to a portfolio due to this purchase was 1.02%. The holding were 80,000 shares as of 2021-06-30.

Integral Health Asset Management, LLC added to a holding in Fate Therapeutics Inc by 100.00%. The purchase prices were between $67.25 and $92.52, with an estimated average price of $80.57. The stock is now traded at around $74.050000. The impact to a portfolio due to this purchase was 0.96%. The holding were 80,000 shares as of 2021-06-30.

Integral Health Asset Management, LLC sold out a holding in Charles River Laboratories International Inc. The sale prices were between $289.83 and $371.65, with an estimated average price of $332.71.

Integral Health Asset Management, LLC sold out a holding in McKesson Corp. The sale prices were between $184.89 and $202.68, with an estimated average price of $193.18.

Integral Health Asset Management, LLC sold out a holding in Centene Corp. The sale prices were between $59.49 and $74.31, with an estimated average price of $68.44.

Integral Health Asset Management, LLC sold out a holding in Merck & Co Inc. The sale prices were between $70.26 and $77.77, with an estimated average price of $74.29.

Integral Health Asset Management, LLC sold out a holding in Laboratory Corp of America Holdings. The sale prices were between $251.87 and $278.14, with an estimated average price of $265.01.

Integral Health Asset Management, LLC sold out a holding in Macrogenics Inc. The sale prices were between $20.49 and $35.63, with an estimated average price of $29.41.

Integral Health Asset Management, LLC reduced to a holding in Intellia Therapeutics Inc by 82.35%. The sale prices were between $60.88 and $161.91, with an estimated average price of $77.89. The stock is now traded at around $154.760000. The impact to a portfolio due to this sale was -3.26%. Integral Health Asset Management, LLC still held 30,000 shares as of 2021-06-30.

Integral Health Asset Management, LLC reduced to a holding in Envista Holdings Corp by 47.83%. The sale prices were between $40.8 and $45.48, with an estimated average price of $43.3. The stock is now traded at around $43.575000. The impact to a portfolio due to this sale was -1.95%. Integral Health Asset Management, LLC still held 180,000 shares as of 2021-06-30.

Integral Health Asset Management, LLC reduced to a holding in Danaher Corp by 62.5%. The sale prices were between $225.08 and $271.69, with an estimated average price of $249.44. The stock is now traded at around $325.360000. The impact to a portfolio due to this sale was -1.63%. Integral Health Asset Management, LLC still held 15,000 shares as of 2021-06-30.

Integral Health Asset Management, LLC reduced to a holding in Acadia Healthcare Co Inc by 24.64%. The sale prices were between $56.8 and $67.8, with an estimated average price of $62.56. The stock is now traded at around $66.920000. The impact to a portfolio due to this sale was -1.41%. Integral Health Asset Management, LLC still held 260,000 shares as of 2021-06-30.

Integral Health Asset Management, LLC reduced to a holding in Zimmer Biomet Holdings Inc by 36.36%. The sale prices were between $157.54 and $178.61, with an estimated average price of $166.66. The stock is now traded at around $149.890000. The impact to a portfolio due to this sale was -0.93%. Integral Health Asset Management, LLC still held 35,000 shares as of 2021-06-30.

Integral Health Asset Management, LLC reduced to a holding in BioCryst Pharmaceuticals Inc by 68.75%. The sale prices were between $9.5 and $17.24, with an estimated average price of $13.51. The stock is now traded at around $15.755000. The impact to a portfolio due to this sale was -0.81%. Integral Health Asset Management, LLC still held 125,000 shares as of 2021-06-30.